Abstract
It has been suggested that the glycosaminoglycans (GAGs) heparan sulfate (HS) and chondroitin sulfate (CS) inhibit calcium oxalate (CaOx) crystallization in vitro 1. Moreover we have previously found that stone forming subjects excrete lower levels of GAGs compared to non-stone formers2. Thus, since GAGs may inhibit calculi growth in vivo, we tested the effect of administering CS to rats using an experimental model of lithiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WG Robertson, M Peacock, BEC Nordin, Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro, Clin Chim Acta 43: 31 (1973).
YM Michelacci, RQ Clashan, N Schor, Urinary excretion of glycosaminoglycans in normal and stone forming subjects, Kidney Int 36: 1022 (1989).
JL Meyer, LH Smith, Growth of calcium oxalate crystals. I. Model of urinary stone growth. Invest Urol 13: 31 (1975).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Boim, M.A., Bergamaschi, C.T., Michelacci, Y.M., Schor, N. (1994). Effects of Glycosaminoglycans on Experimental Urolithiasis in Rats. In: Ryall, R., Bais, R., Marshall, V.R., Rofe, A.M., Smith, L.H., Walker, V.R. (eds) Urolithiasis 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2556-1_72
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2556-1_72
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6091-9
Online ISBN: 978-1-4615-2556-1
eBook Packages: Springer Book Archive